NCT06367465 Feasibility and Acceptability of HCV Treatment in Pregnancy
| NCT ID | NCT06367465 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Washington University School of Medicine |
| Condition | Hepatitis C |
| Study Type | OBSERVATIONAL |
| Enrollment | 50 participants |
| Start Date | 2024-02-01 |
| Primary Completion | 2026-12-28 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 50 participants in total. It began in 2024-02-01 with a primary completion date of 2026-12-28.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Pregnant adults over the age of 18 who are seen in the Washington University obstetrics and gynecology, maternal fetal medicine or infectious diseases clinic or admitted to BJH with hepatitis C virus infection who have a history of past or current drug use Participant Duration: Approximately 1 year. Aims: Aim 1 - Evaluate adherence and treatment completion rates when glecaprevir-pibrentasvir is started during pregnancy for women who use drugs. Aim 2 - Evaluate patient experience with hepatitis C virus treatment during pregnancy.
Eligibility Criteria
Inclusion Criteria: * Female patients ≥ 18 years old, pregnant at the time of study intake, diagnosed with hepatitis c virus infection and a history of past or current drug use. Exclusion Criteria: \-
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06367465 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Hepatitis C. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06367465 currently recruiting?
Yes, NCT06367465 is actively recruiting participants. Contact the research team at habrockt@wustl.edu for enrollment information.
Where is the NCT06367465 trial being conducted?
This trial is being conducted at St Louis, United States, St Louis, United States.
Who is sponsoring the NCT06367465 clinical trial?
NCT06367465 is sponsored by Washington University School of Medicine. The trial plans to enroll 50 participants.